THE Australian Self Medication Industry (ASMI) has elected Theresa Agnew, GSK Consumer Healthcare Area General Manager Australia and NZ to its Board of Directors.
Last week's ASMI annual general meeting in Canberra also saw the re-election of Doug Cunningham, MD Johnson & Johnson Pacific and Mark Sargent, GM ANZ Consumer Health Care for Bayer Australia to the organisation's board.
Elected directors hold office for two years and join the rest of the board including Robert Barnes of Aspen, Glen Cochran from Reckitt Benckiser, Andrew Jenkin of Pfizer, Alan Oppenheim of Ego, Seona Wallace from HealthOne, and Chairperson Lindsay Forrest.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Dec 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Dec 18
